Phlow gets $354 million U.S. funding to ensure drug supply amid COVID-19
May 19, 2020Oil rises on signs of output cuts and demand hopes
May 19, 2020Trump signs deal with company in effort shift drug manufacturing to U.S.: New York Times
at
The United States will announce on Tuesday that it has signed a $354 million contract with a company to make generic medicines and pharmaceutical ingredients in the country needed to treat COVID-19, the New York Times reported late on Monday.
Powered by WPeMatico
